Today, SCIENION and its subsidiary Cellenion, both companies part of the bioconvergence powerhouse BICO, announced the release of the proteoCHIP LF 48. This chip represents the first commercially available solution […]
Autor: Firma Scienion
SCIENION announces expansion in the UK with the opening of new R&D and manufacturing facilities
Together with numerous guests from politics, economics, life sciences and medical diagnostics, SCIENION the precision liquid handling specialist and part of bioconvergence powerhouse BICO, today celebrated the opening of new […]
Highfield Diagnostics and SCIENION Sign Memorandum of Understanding
Highfield Diagnostics Ltd (HDx) and SCIENION GmbH have signed a Memorandum of Understanding (MoU) regarding the development and deployment of equipment which can mass manufacture lateral flow tests (LFTs) that […]
SCIENION Appoints Frauke Hein as CEO
SCIENION GmbH, a BICO company and the precision liquid handling technology company powering life sciences and diagnostics for the future of health, today appointed Dr. Frauke Hein as co-Chief Executive […]
SCIENION bestellt Frauke Hein als CEO
Die SCIENION GmbH, ein BICO-Unternehmen und Anbieter von Präzisions-Flüssigkeitstechnologien, die Life Sciences und Diagnostik für die Zukunft der Gesundheit voranbringen, hat heute Dr. Frauke Hein mit sofortiger Wirkung zum Co-Chief […]
SCIENION celebrates the laying of the foundation stone for new headquarters in Berlin Adlershof
Together with numerous guests from politics, economics and science, SCIENION GmbH today celebrated the laying of the foundation stone of its new headquarters in Berlin Adlershof. The building complex will […]
SCIENION GmbH feiert Grundsteinlegung für neue Unternehmenszentrale in Berlin Adlershof
Die SCIENION GmbH hat heute mit zahlreichen Gästen aus Politik, Wirtschaft und Wissenschaft die Grundsteinlegung zum Neubau ihrer neuen Unternehmenszentrale in Berlin Adlershof gefeiert. Hier entsteht nun auf einer Fläche […]
GILUPI and SCIENION announce Collaboration for the Development of Single-Cell CTC Analysis
GILUPI GmbH and SCIENION AG today announced that the companies intend to intensify their collaboration in the field of single circulating tumor cell (CTC) analysis. CTCs are rare cells that […]
SCIENION continues to grow and will build new headquarters in Berlin Adlershof
SCIENION AG, located in the Technology Park Adlershof since its foundation in 2001, today announced that the expanding company will build larger new headquarters at Wagner-Régeny Street in the same […]
SCIENION AG expandiert weiter und baut neue Unternehmenszentrale in Berlin Adlershof
Die SCIENION AG, die bereits seit Firmengründung 2001 im Technologiepark Adlershof ansässig ist, vergrößert sich weiter und baut ihren neuen Hauptsitz an der Wagner-Régeny-Straße in Berlin Adlershof. Für das 3.037 […]